Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- ChecktodayChange DetectedDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to reflect a new phase I trial involving the drug Trastuzumab and mFOLFOX7 for treating gastric and esophageal cancers, with significant changes in the trial's structure and collaborators. The previous version's detailed description of the trial's cohorts and inclusion criteria has been largely removed.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and changed a date from 2025-03-25 to 2025-01-15.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and its last update date of January 15, 2025.SummaryDifference0.2%
Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.